Found 46 results in Expert Content

Summary: Zydis® orally disintegrating tablet (ODT) technology creates a unique, freeze-dried oral solid dosage form that disperses almost instantly in the mouth, without water. With more than 35 products launched in 60+ countries, Zydis is the world’s fastest and best-in-class ODT.

In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.

Summary: In this webinar, participants will both hear a panel of industry experts discuss practical challenges in oral drug development and gain valuable insights into current approaches to overcoming challenges in developing oral dosage forms that are more patient-friendly.

Summary: This article explores the needs of different patient groups, identifies frequent issues leading to non-compliance, looks at the role of orally disintegrating tablets (ODTs) in helping improve patient compliance, and provides examples of improving the delivery profile of the drug.

Summary: In this executive summary, we describe the benefits of controlled release, how to determine whether a drug is suitable for controlled release and more.

Summary: Experts provide an overview of why the properties and structure of pectin are well suited for site-specific delivery to the colon.

Summary: To rapidly screen macromolecules’ potential for oral delivery, it is critical to assess multiple enabling technologies in parallel, targeting different biological barriers.

This executive summary includes evidence on how the right guidance at the right time can help you create more successful treatments.

Summary: OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders.

Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.